SCHEMBL18856495

SCHEMBL18856495

Cc1cc2c(cc1[N+](=O)[O-])CCCC(=O)C2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ TSHR P16473 3/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ ALDH3A1 P30838 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ GRIN2D O15399 1/20 0.35
▸ GRIN3B O60391 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2A Q12879 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ GRIN2C Q14957 1/20 0.35
▸ GRIN3A Q8TCU5 1/20 0.35
▸ CRHBP P24387 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ MCOLN3 Q8TDD5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3823148 0.88 TSHR (0.44) HPGDALDH1A1TSHRCYP3A4RECQL
SCHEMBL1025994 0.76 KMT2A (0.44) HPGDALDH1A1TSHRCYP3A4RECQL
SCHEMBL6999879 0.74 SMN1; SMN2 (0.44) ALDH1A1CYP3A4NPC1RAB9AMAPT
SCHEMBL7000490 0.74 SMN1; SMN2 (0.44) ALDH1A1CYP3A4NPC1RAB9AMAPT
SCHEMBL34474101 0.73 ALDH1A1 (0.43) HPGDALDH1A1TSHRCYP3A4RECQL
SCHEMBL8113298 0.71 HSD17B1 (0.37) ALDH1A1NPC1RAB9AMAPK1MAPT
SCHEMBL9452619 0.71 MAPT (0.41) HPGDALDH1A1TSHRCYP3A4NPC1
SCHEMBL10229556 0.71 TDP2 (0.49) ALDH1A1NPC1RAB9AMAPTGRIN2B
SCHEMBL5145572 0.71 PNMT (0.51) ALDH1A1NPC1RAB9AMAPTGRIN2B
SCHEMBL18875031 0.70 PNMT (0.54) ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2684874-B1 Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and C-met inhibitors CEPHALON INC (US) 2017-05-17 — — EP disclosed
Send feedback